cancer - International Pharmaceutical Industry

Volume 15 Issue 3

Antibody Drug Conjugates and the Link to Fighting Cancer

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...

29 September 2023 Volume 15 Issue 3 ADCs | antibody

Continue Reading →

Volume 15 Issue 2

How to Harness the Benefits of Inhalation When Re-formulating Biologics

The biologics market is growing rapidly and is on track to be worth $719.14 bn by 2030, up from $366.6 bn in 2021.¹ This growth is being driven primarily by the risi...

3 July 2023 Volume 15 Issue 2 Benefits | biologics

Continue Reading →

News

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments

New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA – July 27, 2022 – PCI Pharma Ser...

27 July 2022 News cancer | clinical

Continue Reading →

News

Late cancer diagnoses rise as NHS struggles with COVID-19

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-1...

1 December 2021 News breast cancer | cancer

Continue Reading →

News

Nykode Therapeutics partners with Regeneron to develop cancer and infectious disease vaccines

Nykode Therapeutics, a clinical-stage biopharmaceutical company, announced that it has entered into a collaboration agreement with Regeneron. This partnership wil...

24 November 2021 News cancer | infectious disease

Continue Reading →

News

Women’s Health Company to Expand

Cervical cancer if not caught early in the precancerous stage can be deadly. Approximately 250,000 women die each year around the world due to the disease, according...

17 July 2018 News cancer | cervical

Continue Reading →

News

Oxford Cancer Biomarkers launches ToxNav to improve morbidity and mortality rates in patients undergoing CRC chemotherapy

Oxford Cancer Biomarkers Limited has announced the launch of ToxNav - a genomic test to identify cancer patients at high risk of severe and potentially fa...

3 July 2018 News biomarkers | cancer

Continue Reading →

News

New Cancer Target Identified for Albumin Enabled Anti-Cancer Therapeutics

Aarhus University's Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate th...

26 June 2018 News albumin | anti-cancer

Continue Reading →

News

Agendia’s MammaPrint® and BluePrint® Breast Cancer Tests Selected by Unicancer for French Patients

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announce that Unicancer, a hospital group entirely devoted to fighting cance...

15 May 2018 News Agendia | Blueprint

Continue Reading →

News

AZ’ lung cancer drug Tagrisso backed for first-line use

European regulatory advisors are supporting approval of AstraZeneca’s lung cancer drug Tagrisso in the first-line setting. The Committee for Medicinal Products ...

1 May 2018 News AZ | backed

Continue Reading →